These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38551531)

  • 1. Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications.
    Rasaratnam N; Salim A; Blackberry I; Cooper ME; Magliano DJ; van Wijngaarden P; Varadarajan S; Sacre JW; Shaw JE
    Am J Kidney Dis; 2024 Jul; 84(1):8-17.e1. PubMed ID: 38551531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological Variability of Estimated GFR and Albuminuria in CKD.
    Waikar SS; Rebholz CM; Zheng Z; Hurwitz S; Hsu CY; Feldman HI; Xie D; Liu KD; Mifflin TE; Eckfeldt JH; Kimmel PL; Vasan RS; Bonventre JV; Inker LA; Coresh J;
    Am J Kidney Dis; 2018 Oct; 72(4):538-546. PubMed ID: 30031564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-grade albuminuria is associated with early but not late carotid atherosclerotic lesions in community-based patients with type 2 diabetes.
    Li MF; Tu YF; Li LX; Lu JX; Dong XH; Yu LB; Zhang R; Bao YQ; Jia WP; Hu RM
    Cardiovasc Diabetol; 2013 Jul; 12():110. PubMed ID: 23883448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Jongs N; Greene T; Chertow GM; McMurray JJV; Langkilde AM; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Heerspink HJL;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):755-766. PubMed ID: 34619106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
    Bakris GL; Agarwal R; Chan JC; Cooper ME; Gansevoort RT; Haller H; Remuzzi G; Rossing P; Schmieder RE; Nowack C; Kolkhof P; Joseph A; Pieper A; Kimmeskamp-Kirschbaum N; Ruilope LM;
    JAMA; 2015 Sep; 314(9):884-94. PubMed ID: 26325557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Day-to-day variability in spot urine albumin-creatinine ratio.
    Naresh CN; Hayen A; Weening A; Craig JC; Chadban SJ
    Am J Kidney Dis; 2013 Dec; 62(6):1095-101. PubMed ID: 23958401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing albuminuria in spot morning samples from diabetic patients.
    Sampaio E; Delfino VD
    Arq Bras Endocrinol Metabol; 2008 Dec; 52(9):1482-8. PubMed ID: 19197457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
    Cherney DZI; Zinman B; Inzucchi SE; Koitka-Weber A; Mattheus M; von Eynatten M; Wanner C
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):610-621. PubMed ID: 28666775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus.
    Chang LH; Chang TT; Chu CH; Huang CC; Lin LY
    Clin Chim Acta; 2024 May; 558():117880. PubMed ID: 38555050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of exercise on albuminuria in people with diabetes.
    Koh KH; Dayanath B; Doery JC; Polkinghorne KR; Teede H; Kerr PG
    Nephrology (Carlton); 2011 Nov; 16(8):704-9. PubMed ID: 21854502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary non-albumin protein-creatinine ratio is an independent predictor of mortality in patients with type 2 diabetes: a retrospective cohort study.
    Cheng YC; Lu CL; Hsu CY; Sheu ML; Lee IT
    Sci Rep; 2024 May; 14(1):10526. PubMed ID: 38719892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stronger Association of Albuminuria with the Risk of Vascular Complications than Estimated Glomerular Filtration Rate in Type 2 Diabetes.
    Hong X; Huang L; Zhang Y; Shen X; Weng S; Zeng F; Zhao F; Yan S
    Kidney Blood Press Res; 2021; 46(5):550-562. PubMed ID: 34428770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Neutrophil Gelatinase-Associated Lipocalin Is Complementary to Albuminuria in Diagnosis of Early-Stage Diabetic Kidney Disease in Type 2 Diabetes.
    Gala-Błądzińska A; Dumnicka P; Kuśnierz-Cabala B; Rybak K; Drożdż R; Żyłka A; Kuźniewski M
    Biomed Res Int; 2017; 2017():4691389. PubMed ID: 28845433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
    de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
    Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Fung CS; Wan EY; Chan AK; Lam CL
    BMC Nephrol; 2017 Feb; 18(1):47. PubMed ID: 28152985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The longitudinal effect of subclinical hypothyroidism on urine microalbumin-to-urine creatinine ratio in patients with type 2 diabetes mellitus.
    Xie J; Wang X; Zhang Y; Li H; Xu Y; Zheng D
    BMC Endocr Disord; 2019 Aug; 19(1):84. PubMed ID: 31382952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study).
    Kinguchi S; Wakui H; Ito Y; Kondo Y; Azushima K; Osada U; Yamakawa T; Iwamoto T; Yutoh J; Misumi T; Aoki K; Yasuda G; Yoshii T; Yamada T; Ono S; Shibasaki-Kurita T; Hosokawa S; Orime K; Hanaoka M; Sasaki H; Inazumi K; Yamada T; Kobayashi R; Ohki K; Haruhara K; Kobayashi Y; Yamanaka T; Terauchi Y; Tamura K
    Cardiovasc Diabetol; 2019 Aug; 18(1):110. PubMed ID: 31455298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial.
    Pollock C; Stefánsson B; Reyner D; Rossing P; Sjöström CD; Wheeler DC; Langkilde AM; Heerspink HJL
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):429-441. PubMed ID: 30992195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy.
    Zelmanovitz T; Gross JL; Oliveira JR; Paggi A; Tatsch M; Azevedo MJ
    Diabetes Care; 1997 Apr; 20(4):516-9. PubMed ID: 9096972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.